Stay updated on ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. The page content and study details appear unchanged.
    Difference
    0.1%
    Check dated 2026-01-14T03:12:49.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Adds a Locations section listing participating sites in Illinois, Michigan, North Carolina, Ohio, Oregon, Pennsylvania, and South Carolina, and updates the page revision to v3.3.3.
    Difference
    1.0%
    Check dated 2025-12-23T20:40:02.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a new revision label v3.3.2, and the previous v3.2.0 label has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:42:12.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Administrative banner about government funding status was removed from the page; this notice did not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:55:08.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The new screenshot shows only minor visual and layout adjustments with no changes to core content or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T20:56:26.000Z thumbnail image
  8. Check
    106 days ago
    Change Detected
    Summary
    - Removed version v3.1.0 and added notice about government funding lapse and current NIH Clinical Center status with links, plus new version tag v3.2.0. The page now communicates operating status details and a newer software version.
    Difference
    6%
    Check dated 2025-10-06T05:20:14.000Z thumbnail image

Stay in the know with updates to ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACP-196/Pembrolizumab in Urothelial Bladder Cancer Clinical Trial page.